Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
PR Newswire

News of the day

Mentice Appoints Bj

13th October 2008 GOTHENBURG, Sweden, October 13 /PRNewswire/ -- Mentice, a leading supplier of solutions for medical simulation, announces the appointment of Mr. Bj more

Evalve Expands Executive Leadership Team

9th October 2008 MENLO PARK, California, October 9 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, has expanded its sales and marketing executive team with the appointment of Sean Cleary as senior vice president of worldwide sales and marketing and Chris Richardson, as vice president of sales. "The addition of Sean and Chris to our executive team is purposefully timed with our European market introduction of the MitraClip(R) system... more

Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio

8th October 2008 COPENHAGEN, October 8 /PRNewswire/ -- Genmab A/S (OMX: GEN) announced today that it is discontinuing development of zanolimumab (HuMax-CD4(R)). In addition, as a result of a portfolio review and assessment of the organization, Genmab is reducing its headcount by 101 positions. As the company approaches potential commercialization, the need to establish a sustainable level of R&D investment is a key priority. Genmab has conducted a review of its portfolio and organization to establish... more
Personnel Announcements RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
Category
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

More recent news

Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
1st October 2008 RICHMOND, California, October 1 /PRNewswire/ -- Lumiphore, Inc., a biotechnology leader in the development of new proprietary fluorescent metal-lanthanide technology for use in...

Appointment Notice - Comprehensive Care International Appoints Healthcare Executive Anthony DiCaita as Project Director for Children's Cancer Hospital 57357
29th September 2008 TORONTO, September 29 /PRNewswire/ -- Comprehensive Care International (CCI), is pleased to announce the appointment of Anthony DiCaita, CMA, CHE, MBA, MPA, as Project Director for the Children's...

Shire Limited: Results of the Annual General Meeting Held on September 24, 2008
24th September 2008 DUBLIN, Ireland, September 24 /PRNewswire/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that at its Annual General Meeting today, all...

SoluBest Appoints Michael Sheckler, MBA, as CEO
10th September 2008 TEL AVIV, Israel, September 10 /PRNewswire/ -- SoluBest Ltd., a privately held, clinical stage developer of a novel solubilizing technology, has appointed Michael Sheckler, MBA, as CEO. Mr. Sheckler...

InNexus Biotechnology Strengthens Patent Team With New Leadership
9th September 2008 BRITISH COLUMBIA, Canada, September 9 /PRNewswire/ -- InNexus Biotechnology Inc., (TSX: IXS.V, OTC Bulletin Board: IXSBF, http://www.ixsbio.com), a drug development company commercializing the...

ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
28th August 2008 LEUVEN, Belgium, August 28 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on novel therapies for eye disease, vascular disease and cancer, announces today...

Essilor : Nomination of Hubert Sagnieres
28th August 2008 CHARENTON-LE-PONT, France, August 28 /PRNewswire/ -- The Board of Directors of Essilor International today appointed Hubert Sagnieres as Chief Operating Officer, to serve alongside Xavier Fontanet,...

Australian to Lead the World in Cancer Fight
27th August 2008 MELBOURNE, Australia, August 27 /PRNewswire/ -- Professor David Hill, Director of The Cancer Council Victoria, will commence in his role as President of the International Union Against Cancer (UICC)...

Allied World Assurance Company Appoints Patrick de Saint-Aignan to Board of Directors
26th August 2008 PEMBROKE, Bermuda, August 26 /PRNewswire/ -- Allied World Assurance Company Holdings, Ltd (NYSE: AWH) today announced the appointment of Patrick de Saint-Aignan to its Board of Directors. Mr....

UltraShape Appoints Assaf Eyal as President & CEO
26th August 2008 YOQNEAM, Israel and SAN RAMON, California, August 26 /PRNewswire/ -- UltraShape, the global leader in non-invasive fat reduction and body contouring, announced today the appointment of Assaf Eyal as...

Chiltern's Resourcing Solutions Division Appoints New Managers to Spain and the United Kingdom
7th August 2008 LONDON, August 7 /PRNewswire/ -- Chiltern, a leading global research organization, announced that it has appointed new staff in strategic locations to support the large growth in their Resourcing...

Pollogen Announces Appointment of Ms. Yfat Scialom as Chief Executive Officer
5th August 2008 TEL AVIV, Israel, BADAJOZ, Spain and SINGAPORE, August 5 /PRNewswire/ -- Pollogen Ltd. announced that Ms. Yfat Scialom has been appointed as the new Chief Executive Officer effective July 20, 2008. ...

Assist America Appoints Abhijit Bhandari as Director of Sales & Marketing for the Middle East
25th July 2008 PRINCETON, New Jersey, July 25 /PRNewswire/ -- Assist America, Inc., the world's leading global emergency assistance services provider through group benefit plans, announced today that...

Shire Ltd.: Robin Buchanan to Step Down as Non-Executive Director on Completion of Term of Office
21st July 2008 BASINGSTOKE, England and PHILADELPHIA, Pennsylvania, July 21 /PRNewswire/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company announces that non-executive...

Organizational Changes at Silence Therapeutics
17th July 2008 LONDON, July 17 /PRNewswire/ -- Silence Therapeutics plc (London AIM: SLN), a leading European RNAi focused biotechnology company, announces that for personal reasons, Jeffery Vick has resigned as...

AMT Appoints Director Global Marketing and Sales
17th July 2008 AMSTERDAM, The Netherlands, July 17 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today the appointment of Mrs. Janneke de...

Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board
14th July 2008 NOVATO, California, July 14 /PRNewswire/ -- Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), today announced the appointments of Richard L. Franklin, M.D., Ph.D. to the Company's board of...

Cohn & Wolfe Launches GCI Health, One of the World's Largest Healthcare Public Relations Firms
9th July 2008 NEW YORK, July 9 /PRNewswire/ -- Cohn & Wolfe has announced the formation of GCI Health, a new global healthcare public relations firm, specializing in all aspects of the healthcare industry. GCI...

Physicians Practice Promotes Key Executives
7th July 2008 BALTIMORE, July 7 /PRNewswire/ -- Physicians Practice, America's Leading Practice Management Journal today announced the promotions of Pamela L. Moore, Ph.D to editorial director, Steven Gottshall to...

A New President at the Head of the Genethon Laboratory
7th July 2008 EVRY, France, July 7 /PRNewswire/ -- The board of directors at Genethon nominated a new president to head the laboratory created in 1990 by the AFM (French Muscular Dystrophy Association). Thus Yves...

Nabriva Therapeutics Announces Appointment of New CEO
3rd July 2008 VIENNA, Austria, July 3 /PRNewswire/ -- Nabriva Therapeutics, a specialist in antibiotics development, announces that Dr. George Golumbeski has been appointed as Chief Executive Officer of the...

Silence Therapeutics Announces Board Changes
1st July 2008 LONDON, July 1 /PRNewswire/ -- Silence Therapeutics plc (London AIM: SLN) ('the Company') today announced changes to its Board of Directors as part of the company's plan for growth. Effective...

Pinnacle Biologics Announces Opening of Executive Offices in Bannockburn, Illinois and the Addition of Sandra Miller to the Board of Directors
1st July 2008 BANNOCKBURN, Illinois, July 1 /PRNewswire/ -- Pinnacle Biologics, a private, full-service pharmaceutical and biotech solutions company today announced it has entered into a lease agreement...

Nucletron Appoints New Chief Executive Officer
30th June 2008 VEENENDAAL, The Netherlands, June 30 /PRNewswire/ -- Nucletron announced today the appointment of Jos Lamers as its new chief executive officer. The appointment marks the next phase for the...

Niutang Recruits Seasoned Executive to Open U.K. Office
23rd June 2008 CHANGZHOU, China, June 23 /PRNewswire/ -- Niutang Chemical, a leading global manufacturer of food additives, pharmaceutical intermediates and curing agents, has recruited Alan Turner to lead its new...

Bruce Palsulich Joins Relsys International as Chief Innovation & Strategy Officer
23rd June 2008 IRVINE, California, June 23 /PRNewswire/ -- Relsys International, the leading provider of drug safety, pharmacovigilance and risk management solutions for the pharmaceutical industry, announces that...

Senetek PLC Announces Key Personnel Appointments
9th June 2008 NAPA, California, June 9 /PRNewswire/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today...

Amira Pharmaceuticals Hires Industry Veteran for CFO Position
9th June 2008 SAN DIEGO, June 9 /PRNewswire/ -- Amira Pharmaceuticals, a small molecule pharmaceutical company focused on the discovery and development of compounds to treat inflammatory diseases, announced the...

Ex-Menarini Executive to Lead UK for WaveSense
5th June 2008 OXFORD, England, June 5 /PRNewswire/ -- WaveSense Europe announced today that Mr. Alec Winton, formerly of Menarini Diagnostics, has joined WaveSense Europe as General Manager, UK, and that WaveSense...

Genmab A/S - Changes Board/Management/Auditors
2nd June 2008 COPENHAGEN, Denmark, June 2 /PRNewswire/ -- Genmab A/S (OMX: GEN) today announced that David A. Eatwell has been appointed Chief Financial Officer of the company. Mr. Eatwell will be responsible...

Nventa Appoints Gordon H. Busenbark to Board of Directors
28th May 2008 SAN DIEGO, May 28 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today the appointment of Gordon H. Busenbark to the company's board of directors. Mr. Busenbark currently...

Allergy Standards Ltd. Appoints Angela Southey PhD as Scientific Officer
22nd May 2008 DUBLIN, Ireland, May 22 /PRNewswire/ -- Allergy Standards Ltd. ("ASL"), the internationally recognized independent evaluator of consumer products, today announced that Angela Southey, PhD, has joined...

Teva Welcomes Recognition for Kim Innes as BGMA Chair
20th May 2008 LEEDS, England, May 20 /PRNewswire/ -- Teva UK Limited has welcomed the election of Kim Innes, Director of the company's generics business, as Chairman of the British Generic...

New Supervisory Board Member for Gerresheimer
19th May 2008 DUSSELDORF, Germany, May 19 /PRNewswire/ -- Mr. Lionel Assant, Partner in Blackstone Group International Ltd., London, has resigned his Supervisory Board mandate with Gerresheimer AG. In his...

Chiltern Expands Its Global Reach to Latin America
19th May 2008 LONDON, May 19 /PRNewswire/ -- Chiltern, a leading global research organization, announced the appointment of Mr. Oscar Podesta to the role of General Manager, Latin America. The Latin American...

Albireo Appoints Dr Hans Graffner as Chief Medical Officer
15th May 2008 GOTHENBURG, Sweden, May 15 /PRNewswire/ -- Albireo, a pharmaceutical company focusing on the development of therapeutics for gastrointestinal diseases, announced today the appointment of Hans...

RPS Enhances Clinical Expertise and Leadership with Two Additions to Senior Management Team
14th May 2008 FORT WASHINGTON, Pennsylvania, May 14 /PRNewswire/ -- RPS, Inc. today announced the addition of two new members to its Senior Management Team. David A. Green, Ph.D. joins RPS as Vice President...

ChemAxon Announces New CEO and Head of R&D
12th May 2008 BUDAPEST, Hungary, May 12 /PRNewswire/ -- ChemAxon, a software solutions provider for cheminformatics, today announced the appointment of Alex Drijver as CEO. The arrival signals the companies...

Nventa Appoints John Varian to Board of Directors
7th May 2008 SAN DIEGO, May 7 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) announced today the appointment of John Varian to the company's board of directors. Mr. Varian currently serves as...

Basil Zimmo Joins Finesse Solutions as Vice-President of Software
7th May 2008 SANTA CLARA, California, May 7 /PRNewswire/ -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced...

Kendle Appoints Patricia Williams Vice President, Commercial Operations
6th May 2008 CINCINNATI, May 6 /PRNewswire/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization (CRO), today announced the appointment of Patricia Williams to the position of...

MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
6th May 2008 GAITHERSBURG, Maryland, May 6 /PRNewswire/ -- MedImmune today announced that it has enhanced its leadership team to guide the company's expanded product pipeline in the United States and abroad as...

Jonas Ohlsson Appointed CEO/President of Cellectricon
29th April 2008 GOTHENBURG, Sweden, April 29 /PRNewswire/ -- Cellectricon, a leading provider of screening solutions for drug discovery, announced today that its board of directors has appointed Jonas Ohlsson as the...

Partnering consultation free of charge
Therapeutic Area Partnerships
Bioiberica
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us